We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$169M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$116M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$87.5M
4
ABBV icon
AbbVie
ABBV
+$80.5M
5
JPM icon
JPMorgan Chase
JPM
+$79.3M

Top Sells

Rank Stock Value
1
IGM icon
iShares Expanded Tech Sector ETF
IGM
+$79.2M
2
CMCSA icon
Comcast
CMCSA
+$69.1M
3
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$53.3M
4
META icon
Meta Platforms (Facebook)
META
+$48.1M
5
VZ icon
Verizon
VZ
+$41.8M

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QFIN icon
3451
Qfin Holdings
QFIN
$1.52B
$201K ﹤0.01%
9,865
-1,300
-12% -$19.3K
HDSN
3452
Hudson Technologies
HDSN
$239M
$200K ﹤0.01%
+19,727
New +$193K
CDMO
3453
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$198K ﹤0.01%
14,381
– –
HPS
3454
John Hancock Preferred Income Fund III
HPS
$459M
$198K ﹤0.01%
13,701
-6,118
-31% -$89.1K
SRNE
3455
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$198K ﹤0.01%
223,019
-34,300
-13% -$45.5K
IFN
3456
Aberdeen India Fund
IFN
$505M
$198K ﹤0.01%
13,341
-7,820
-37% -$125K
ETX
3457
Eaton Vance Municipal Income 2028 Term Trust
ETX
$200M
$197K ﹤0.01%
11,072
-5,067
-31% -$94.1K
PXLW icon
3458
Pixelworks
PXLW
$45.7M
$197K ﹤0.01%
9,283
– –
IMGN
3459
DELISTED
Immunogen Inc
IMGN
$197K ﹤0.01%
39,750
-170,987
-81% -$927K
AFB
3460
AllianceBernstein National Municipal Income Fund
AFB
$317M
$197K ﹤0.01%
18,790
+3,842
+26% +$40.1K
AROC icon
3461
Archrock
AROC
$5.85B
$195K ﹤0.01%
21,717
+2,458
+13% +$19.7K
PFO
3462
Flaherty & Crumrine Preferred and Income Opportunity Fund
PFO
$119M
$195K ﹤0.01%
22,672
+3,180
+16% +$28.2K
KURA icon
3463
Kura Oncology
KURA
$896M
$195K ﹤0.01%
15,689
-1,586
-9% -$23.1K
HEQ
3464
John Hancock Hedged Equity & Income Fund
HEQ
$141M
$194K ﹤0.01%
16,907
+541
+3% +$6.38K
VCV icon
3465
Invesco California Value Municipal Income Trust
VCV
$527M
$194K ﹤0.01%
20,500
-69,623
-77% -$645K
NBXG
3466
Neuberger Next Generation Connectivity Fund Inc
NBXG
$1.24B
$194K ﹤0.01%
21,318
+3,518
+20% +$33.4K
YJUN icon
3467
FT Vest International Equity Buffer ETF June
YJUN
$145M
$191K ﹤0.01%
10,337
-163
-2% -$2.88K
IVH
3468
DELISTED
Delaware Ivy High Income Opportunities Fund
IVH
$190K ﹤0.01%
17,372
+6,690
+63% +$70.8K
MAC icon
3469
Macerich
MAC
$6.99B
$190K ﹤0.01%
16,888
-2,435
-13% -$27.5K
PMF
3470
DELISTED
PIMCO Municipal Income Fund
PMF
$190K ﹤0.01%
18,181
+2,087
+13% +$21.6K
EVF
3471
Eaton Vance Senior Income Trust
EVF
$90.9M
$189K ﹤0.01%
35,861
-8,930
-20% -$47.7K
BGFV
3472
DELISTED
Big 5 Sporting Goods
BGFV
$189K ﹤0.01%
21,380
-36,850
-63% -$424K
RDFN
3473
DELISTED
Redfin
RDFN
$189K ﹤0.01%
44,524
-36,769
-45% -$173K
TXN icon
3474
PUT
Texas Instruments
TXN
$250B
$187K ﹤0.01%
+25,300
New +$4.22M
HTBK
3475
DELISTED
Heritage Commerce
HTBK
$187K ﹤0.01%
14,387
-1,216
-8% -$16.4K
137 138
139
140 141

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.